Literature DB >> 8949436

Contact allergy to popular perfumes; assessed by patch test, use test and chemical analysis.

J D Johansen1, S C Rastogi, T Menné.   

Abstract

The frequency of contact allergy to the 10 best-selling women's perfumes was studied in 335 consecutive female eczema patients by patch testing. The diagnostic ability of the fragrance mix, in relation to these products, was evaluated. Of eczema patients, 6.9% had a positive patch test to one or more of the perfumes, and 56.5% of these had a concurrent positive reaction to the fragrance mix. Hence, testing with the patients' own cosmetics is a significant part of diagnosing perfume allergy. The clinical relevance of the patch-test reactions to the commercial perfumes was equal to that of the fragrance mix, as judged from the patient's history and use testing with one of the perfumes. At least three of the chemically defined sensitizers in the fragrance mix were detected in all the perfumes by gas chromatography-mass spectrometry, which indicates that the fragrance mix is a good imitation of actual exposure.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8949436

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN: 0007-0963            Impact factor:   9.302


  3 in total

Review 1.  Ubiquity, Hazardous Effects, and Risk Assessment of Fragrances in Consumer Products.

Authors:  María-Antonia Pastor-Nieto; María-Elena Gatica-Ortega
Journal:  Curr Treat Options Allergy       Date:  2021-01-23

2.  Contact allergic cheilitis secondary to latex gloves: a case report.

Authors:  Shishir Ram Shetty; Anusha Rangare; Subhas Babu; Prasanna Rao
Journal:  J Oral Maxillofac Res       Date:  2011-04-01

3.  Myroxylon pereirae (balsam of Peru): Still worth testing?

Authors:  Fabrizio Guarneri; Monica Corazza; Luca Stingeni; Cataldo Patruno; Maddalena Napolitano; Paolo D M Pigatto; Rosella Gallo; Antonio Cristaudo; Paolo Romita; Annamaria Offidani; Donatella Schena; Nicola Milanesi; Giuseppe Micali; Myriam Zucca; Caterina Foti
Journal:  Contact Dermatitis       Date:  2021-05-03       Impact factor: 6.600

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.